New composition for treating brain cancer by means of platelet-supported thymoquinone extracted from black seed for treating brain cancer with fewer side effects

WO2025254572A1PCT designated stage Publication Date: 2025-12-11KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
PCT/SA2025/000002
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-06-04
Filing Date
2025-03-05
Publication Date
2025-12-11

Smart Images

  • Figure SA2025000002_11122025_PF_FP_ABST
    Figure SA2025000002_11122025_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a therapeutic composition from natural substances that targets cancer cells, specifically brain cancer cells, and to a method for preparing same, wherein the composition comprises: 1) a therapeutic agent extracted from black seed, in the form of thymoquinone and 2) between 238,671 and 1,500,000,000 platelets, wherein components (a) and (b) are dissolved in 1 mL blood plasma proteins.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Preparation method of antitumor drug carrying platelet drug loading system

    CN104771762A